Reference : Cardiometabolic risk: leg fat is protective during childhood.
Scientific journals : Article
Life sciences : Multidisciplinary, general & others
http://hdl.handle.net/10993/26951
Cardiometabolic risk: leg fat is protective during childhood.
English
Samouda, Hanen [> >]
De Beaufort, Carine mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) >]
Stranges, Saverio [> >]
Hirsch, Marco [> >]
Van Nieuwenhuyse, Jean-Paul [> >]
Dooms, Georges [> >]
Gilson, Georges [> >]
Keunen, Olivier [> >]
Leite, Sonia [> >]
Vaillant, Michel [> >]
Lair, Marie-Lise [> >]
Dadoun, Frederic [> >]
17-Jun-2015
Pediatric diabetes
Yes (verified by ORBilu)
1399-543X
1399-5448
[en] DXA ; cardiometabolic risk ; fat mass ; leg fat ; visceral fat
[en] BACKGROUND: Childhood obesity is associated with early cardiometabolic risk (CMR), increased risk of adulthood obesity, and worse health outcomes. Leg fat mass (LFM) is protective beyond total fat mass (TFM) in adults. However, the limited evidence in children remains controversial. OBJECTIVE: We investigated the relationship between LFM and CMR factors in youth. SUBJECTS: A total of 203 overweight/obese children, 7-17-yr-old, followed in the Pediatric Clinic, Luxembourg. METHODS: TFM and LFM by dual energy x-ray absorptiometry and a detailed set of CMR markers were analyzed. RESULTS: After TFM, age, sex, body mass index (BMI) Z-score, sexual maturity status, and physical activity adjustments, negative significant partial correlations were shown between LFM and homeostasis model assessment of insulin resistance (HOMA) (variance explained: 6.05% by LFM*; 7.18% by TFM**), fasting insulin (variance explained: 5.71% by LFM*; 6.97% by TFM**), triglycerides (variance explained: 3.96% by LFM*; 2.76% by TFM*), systolic blood pressure (variance explained: 2.68% by LFM*; 4.33% by TFM*), C-reactive protein (variance explained: 2.31% by LFM*; 4.28% by TFM*), and resistin (variance explained: 2.16% by LFM*; 3.57% by TFM*). Significant positive partial correlations were observed between LFM and high-density lipoprotein (HDL) cholesterol (variance explained: 4.16% by LFM*) and adiponectin (variance explained: 3.09% by LFM*) (*p-value < 0.05 and **p-value < 0.001). In order to adjust for multiple testing, Benjamini-Hochberg method was applied and the adjusted significance level was determined for each analysis. LFM remained significant in the aforementioned models predicting HOMA, fasting insulin, triglycerides, and HDL cholesterol (Benjamini and Hochberg corrected p-value < 0.01). CONCLUSIONS: LFM is protective against CMR in children, at least in terms of insulin resistance and adverse blood lipid profiles.
http://hdl.handle.net/10993/26951
10.1111/pedi.12292
(c) 2015 The Authors. Pediatric Diabetes published by John Wiley & Sons Ltd.

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Samouda_et_al-2015-Pediatric_Diabetes.pdfPublisher postprint120.3 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.